Trials / Recruiting
RecruitingNCT06360536
Remotely Delivered Resistance Training for Cardiometabolic Health Among Black Women
Remotely Delivered Resistance Training for Cardiometabolic Health Among Black Women: A Pilot Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (estimated)
- Sponsor
- University of Alabama at Birmingham · Academic / Other
- Sex
- Female
- Age
- 30 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to collect preliminary data on the feasibility, acceptability, and potential effects of a novel, remotely delivered resistance training program.
Detailed description
This trial will enroll Black women with elevated cardiometabolic risk (e.g., overweight or obesity, pre- or established diabetes, and elevated or high blood pressure) in early-to-middle adulthood (n=36; age=30-64 years) with insufficient resistance training (RT) participation. This 4-month single group pilot trial evaluates the feasibility, acceptability, and potential effects of a novel, remotely-delivered resistance training (RT) intervention. All participants will engage in RT during this trial and the web-based platform is the primary modality through which the remote RT intervention is delivered. Assessments are conducted at baseline and follow-up (month 4). Aim 1 will examine the feasibility and acceptability of the remotely delivered RT program. Aim 2 will examine the potential effects on RT behaviors. Aim 3 will examine the potential effects on clinical and patient-reported outcomes.
Conditions
- Overweight or Obesity
- Prediabetes or Diabetes
- Prehypertension (Elevated Blood Pressure) or Hypertension
- Resistance Training
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Resistance Training | A home-based resistance training condition that is delivered through a web-based platform. |
Timeline
- Start date
- 2025-06-04
- Primary completion
- 2026-06-01
- Completion
- 2026-06-30
- First posted
- 2024-04-11
- Last updated
- 2026-02-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06360536. Inclusion in this directory is not an endorsement.